The Cooper Companies, Inc. (COO) EV/EBIT Ratio: 31.25x
Is The Cooper Companies, Inc.’s EV/EBIT ratio high or low?
The Cooper Companies, Inc.'s EV/EBIT ratio of 31.25x is 12% below its 5-year average of 35.66x, around the middle of its 5-year range (19.58x–54.20x).
As of Sunday, June 14, 2026. 32.03% above its 12-month average of 23.67x.
COO EV/EBIT Ratio Chart
COO Average EV/EBIT Ratio Chart
COO Current vs Average EV/EBIT Ratio Chart
COO EV/EBIT Ratio Metrics
EV/EBIT RATIO
31.25x
EV/EBIT RATIO AVG TTM
23.67x
EV/EBIT RATIO AVG 3Y
31.83x
EV/EBIT RATIO AVG 5Y
35.66x
EV/EBIT RATIO AVG 10Y
37.23x
EV/EBIT RATIO AVG 15Y
32.98x
EV/EBIT RATIO AVG 20Y
30.38x
CURRENT VS TTM AVG
+32.03%
CURRENT VS 3Y AVG
-1.82%
CURRENT VS 5Y AVG
-12.37%
CURRENT VS 10Y AVG
-16.06%
CURRENT VS 15Y AVG
-5.24%
CURRENT VS 20Y AVG
+2.88%
COO Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 31.25x | 23.67x | 31.83x | 35.66x |
| Solventum Corporation (SOLV) | $13.66B | 8.70x | 20.82x | 17.36x | 17.36x |
| Align Technology, Inc. (ALGN) | $12.52B | 19.57x | 19.29x | 26.44x | 31.41x |
| Baxter International Inc. (BAX) | $10.77B | N/A | 442.63x | 243.35x | 134.31x |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | N/A | 25.59x | 34.39x | 25.01x |
| Hologic, Inc. (HOLX) | $16.97B | 24.28x | 22.66x | 24.05x | 18.32x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 25.40x | 62.63x | 38.51x | 35.13x |
| Tempus AI, Inc. (TEM) | $8.35B | N/A | -26.05x | -27.91x | -28.92x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 35.82x | 38.08x | 32.83x | 33.28x |
| Moderna, Inc. (MRNA) | $19.80B | N/A | 23.08x | 30.95x | 30.95x |
The Cooper Companies, Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The EV/EBIT ratio for COO stock is 31.25x.
- Is The Cooper Companies, Inc.'s EV/EBIT ratio high or low?
- The Cooper Companies, Inc.'s EV/EBIT ratio of 31.25x is 12% below its 5-year average of 35.66x, around the middle of its 5-year range (19.58x–54.20x).
- What is the TTM average EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The TTM average EV/EBIT ratio for COO stock is 23.67x.
- What is the 3Y average EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The 3Y average EV/EBIT ratio for COO stock is 31.83x.
- What is the 5Y average EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The 5Y average EV/EBIT ratio for COO stock is 35.66x.
- What is the 10Y average EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The 10Y average EV/EBIT ratio for COO stock is 37.23x.
- What is the 15Y average EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The 15Y average EV/EBIT ratio for COO stock is 32.98x.
- What is the 20Y average EV/EBIT ratio for The Cooper Companies, Inc. (COO)?
- The 20Y average EV/EBIT ratio for COO stock is 30.38x.
The Cooper Companies, Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-12 | 31.25x |
| 2026-06-11 | 31.10x |
| 2026-06-10 | 31.17x |
| 2026-06-09 | 31.54x |
| 2026-06-08 | 30.82x |
| 2026-06-05 | 31.04x |
| 2026-06-04 | 20.42x |
| 2026-06-03 | 19.96x |
| 2026-06-02 | 19.72x |
| 2026-06-01 | 19.92x |
| 2026-05-29 | 20.20x |
| 2026-05-28 | 20.15x |
| 2026-05-27 | 20.08x |
| 2026-05-26 | 20.42x |
| 2026-05-22 | 20.57x |
| 2026-05-21 | 20.65x |
| 2026-05-20 | 20.35x |
| 2026-05-19 | 20.26x |
| 2026-05-18 | 20.12x |
| 2026-05-15 | 19.76x |
| 2026-05-14 | 19.97x |
| 2026-05-13 | 19.72x |
| 2026-05-12 | 19.85x |
| 2026-05-11 | 19.58x |
| 2026-05-08 | 19.86x |
| 2026-05-07 | 20.17x |
| 2026-05-06 | 20.17x |
| 2026-05-05 | 20.21x |
| 2026-05-04 | 20.28x |
| 2026-05-01 | 20.51x |
| 2026-04-30 | 20.66x |
| 2026-04-29 | 20.23x |
| 2026-04-28 | 20.72x |
| 2026-04-27 | 21.06x |
| 2026-04-24 | 21.08x |
| 2026-04-23 | 21.23x |
| 2026-04-22 | 21.77x |
| 2026-04-21 | 21.88x |
| 2026-04-20 | 22.47x |
| 2026-04-17 | 22.64x |
| 2026-04-16 | 22.45x |
| 2026-04-15 | 22.70x |
| 2026-04-14 | 23.06x |
| 2026-04-13 | 23.09x |
| 2026-04-10 | 22.95x |
| 2026-04-09 | 23.02x |
| 2026-04-08 | 23.10x |
| 2026-04-07 | 22.53x |
| 2026-04-06 | 22.70x |
| 2026-04-02 | 22.67x |
| 2026-04-01 | 23.01x |
| 2026-03-31 | 23.03x |
| 2026-03-30 | 22.43x |
| 2026-03-27 | 22.56x |
| 2026-03-26 | 23.04x |
| 2026-03-25 | 23.02x |
| 2026-03-24 | 22.75x |
| 2026-03-23 | 22.69x |
| 2026-03-20 | 22.61x |
| 2026-03-19 | 22.82x |
| 2026-03-18 | 22.94x |
| 2026-03-17 | 23.18x |
| 2026-03-16 | 22.91x |
| 2026-03-13 | 22.60x |
| 2026-03-12 | 23.04x |
| 2026-03-11 | 23.65x |
| 2026-03-10 | 23.84x |
| 2026-03-09 | 24.22x |
| 2026-03-06 | 24.43x |
| 2026-03-05 | 27.18x |
| 2026-03-04 | 27.70x |
| 2026-03-03 | 28.10x |
| 2026-03-02 | 28.26x |
| 2026-02-27 | 28.19x |
| 2026-02-26 | 28.28x |
| 2026-02-25 | 28.13x |
| 2026-02-24 | 28.15x |
| 2026-02-23 | 27.97x |
| 2026-02-20 | 28.30x |
| 2026-02-19 | 28.19x |
| 2026-02-18 | 28.11x |
| 2026-02-17 | 27.68x |
| 2026-02-13 | 27.99x |
| 2026-02-12 | 27.61x |
| 2026-02-11 | 28.01x |
| 2026-02-10 | 27.58x |
| 2026-02-09 | 27.55x |
| 2026-02-06 | 27.73x |
| 2026-02-05 | 27.15x |
| 2026-02-04 | 27.39x |
| 2026-02-03 | 26.93x |
| 2026-02-02 | 27.31x |
| 2026-01-30 | 27.52x |
| 2026-01-29 | 27.23x |
| 2026-01-28 | 27.26x |
| 2026-01-27 | 27.32x |
| 2026-01-26 | 27.38x |
| 2026-01-23 | 27.50x |
| 2026-01-22 | 27.93x |
| 2026-01-21 | 27.86x |
| 2026-01-20 | 27.30x |
| 2026-01-16 | 27.81x |
| 2026-01-15 | 27.79x |
| 2026-01-14 | 27.61x |
| 2026-01-13 | 27.61x |
| 2026-01-12 | 28.06x |
| 2026-01-09 | 28.12x |
| 2026-01-08 | 28.03x |
| 2026-01-07 | 28.25x |
| 2026-01-06 | 28.37x |
| 2026-01-05 | 27.92x |
| 2026-01-02 | 27.44x |
| 2025-12-31 | 27.69x |
| 2025-12-30 | 27.84x |
| 2025-12-29 | 27.76x |
| 2025-12-26 | 27.88x |
| 2025-12-24 | 27.87x |
| 2025-12-23 | 27.96x |
| 2025-12-22 | 28.24x |
| 2025-12-19 | 27.92x |
| 2025-12-18 | 27.83x |
| 2025-12-17 | 27.84x |
| 2025-12-16 | 27.42x |
| 2025-12-15 | 27.56x |
| 2025-12-12 | 27.72x |
| 2025-12-11 | 27.73x |
| 2025-12-10 | 27.34x |
| 2025-12-09 | 26.69x |
| 2025-12-08 | 26.55x |
| 2025-12-05 | 27.53x |
| 2025-12-04 | 24.03x |
| 2025-12-03 | 23.75x |
| 2025-12-02 | 23.71x |
| 2025-12-01 | 24.14x |
| 2025-11-28 | 24.28x |
| 2025-11-26 | 24.28x |
| 2025-11-25 | 24.35x |
| 2025-11-24 | 23.76x |
| 2025-11-21 | 23.61x |
| 2025-11-20 | 22.43x |
| 2025-11-19 | 22.71x |
| 2025-11-18 | 22.72x |
| 2025-11-17 | 22.49x |
| 2025-11-14 | 22.71x |
| 2025-11-13 | 22.60x |
| 2025-11-12 | 22.80x |
| 2025-11-11 | 22.60x |
| 2025-11-10 | 22.32x |
| 2025-11-07 | 22.16x |
| 2025-11-06 | 21.86x |
| 2025-11-05 | 21.83x |
| 2025-11-04 | 21.88x |
| 2025-11-03 | 22.08x |
| 2025-10-31 | 22.10x |
| 2025-10-30 | 22.16x |
| 2025-10-29 | 22.02x |
| 2025-10-28 | 22.60x |
| 2025-10-27 | 22.90x |
| 2025-10-24 | 23.08x |
| 2025-10-23 | 23.35x |
| 2025-10-22 | 23.33x |
| 2025-10-21 | 23.48x |
| 2025-10-20 | 23.48x |
| 2025-10-17 | 22.66x |
| 2025-10-16 | 22.55x |
| 2025-10-15 | 21.79x |
| 2025-10-14 | 22.46x |
| 2025-10-13 | 21.94x |
| 2025-10-10 | 21.69x |
| 2025-10-09 | 22.06x |
| 2025-10-08 | 22.20x |
| 2025-10-07 | 21.86x |
| 2025-10-06 | 22.16x |
| 2025-10-03 | 22.25x |
| 2025-10-02 | 21.89x |
| 2025-10-01 | 21.61x |
| 2025-09-30 | 21.74x |
| 2025-09-29 | 21.50x |
| 2025-09-26 | 21.47x |
| 2025-09-25 | 21.29x |
| 2025-09-24 | 21.68x |
| 2025-09-23 | 21.45x |
| 2025-09-22 | 21.59x |
| 2025-09-19 | 21.63x |
| 2025-09-18 | 21.38x |
| 2025-09-17 | 20.59x |
| 2025-09-16 | 20.82x |
| 2025-09-15 | 20.91x |
| 2025-09-12 | 21.23x |
| 2025-09-11 | 21.71x |
| 2025-09-10 | 21.50x |
| 2025-09-09 | 21.66x |
| 2025-09-08 | 21.80x |
| 2025-09-05 | 21.61x |
| 2025-09-04 | 21.59x |
| 2025-09-03 | 21.35x |
| 2025-09-02 | 20.86x |
| 2025-08-29 | 21.43x |
| 2025-08-28 | 20.66x |
| 2025-08-27 | 22.89x |
| 2025-08-26 | 22.77x |
| 2025-08-25 | 22.72x |
| 2025-08-22 | 23.18x |
| 2025-08-21 | 22.61x |
| 2025-08-20 | 22.73x |
| 2025-08-19 | 22.87x |
| 2025-08-18 | 22.74x |
| 2025-08-15 | 22.66x |
| 2025-08-14 | 22.71x |
| 2025-08-13 | 22.93x |
| 2025-08-12 | 22.51x |
| 2025-08-11 | 22.03x |
| 2025-08-08 | 21.88x |
| 2025-08-07 | 21.59x |
| 2025-08-06 | 21.30x |
| 2025-08-05 | 21.68x |
| 2025-08-04 | 22.18x |
| 2025-08-01 | 22.03x |
| 2025-07-31 | 21.98x |
| 2025-07-30 | 22.40x |
| 2025-07-29 | 22.78x |
| 2025-07-28 | 22.57x |
| 2025-07-25 | 23.02x |
| 2025-07-24 | 22.81x |
| 2025-07-23 | 22.70x |
| 2025-07-22 | 22.60x |
| 2025-07-21 | 22.15x |
| 2025-07-18 | 22.50x |
| 2025-07-17 | 22.66x |
| 2025-07-16 | 22.52x |
| 2025-07-15 | 22.38x |
| 2025-07-14 | 22.76x |
| 2025-07-11 | 23.06x |
| 2025-07-10 | 23.58x |
| 2025-07-09 | 23.11x |
| 2025-07-08 | 22.93x |
| 2025-07-07 | 22.67x |
| 2025-07-03 | 22.67x |
| 2025-07-02 | 22.60x |
| 2025-07-01 | 22.54x |
| 2025-06-30 | 22.11x |
| 2025-06-27 | 22.10x |
| 2025-06-26 | 21.72x |
| 2025-06-25 | 21.68x |
| 2025-06-24 | 22.05x |
| 2025-06-23 | 21.67x |
| 2025-06-20 | 21.66x |
| 2025-06-18 | 21.75x |
| 2025-06-17 | 21.47x |
| 2025-06-16 | 21.73x |
| 2025-06-13 | 21.72x |
| 2025-06-12 | 22.03x |
| 2025-06-11 | 22.18x |
| 2025-06-10 | 22.51x |
| 2025-06-09 | 22.32x |
| 2025-06-06 | 22.42x |
| 2025-06-05 | 22.11x |
| 2025-06-04 | 21.12x |
| 2025-06-03 | 20.98x |
| 2025-06-02 | 21.01x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White